HNWAG
PAHC icon

High Net Worth Advisory Group’s Phibro Animal Health PAHC Stock Holding History

High Net Worth Advisory Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-605
Closed -$12K – 711
2022
Q2 		$12K Hold
605
– – 0.01% 510
2022
Q1 		$12K Hold
605
– – ﹤0.01% 513
2021
Q4 		$12K Buy
+605
New +$12.9K ﹤0.01% 522

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

High Net Worth Advisory Group's PAHC Position: Q3 2022 in Review

High Net Worth Advisory Group sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 605 shares — an estimated $12K sold.

High Net Worth Advisory Group first reported a position in PAHC in Q4 2021 and held it in 3 quarters. The position peaked at $12K in Q2 2022. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • High Net Worth Advisory Group reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 605 Phibro Animal Health shares in Q3 2022, an estimated $12K.
  • High Net Worth Advisory Group first reported a position in Phibro Animal Health in Q4 2021 and held it in 3 quarters.
  • High Net Worth Advisory Group's Phibro Animal Health position peaked at $12K in Q2 2022.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on High Net Worth Advisory Group's 13F filing for Q3 2022, filed 24 Oct 2022.